Unlocking the phytochemicals in unopened pitcher fluids of Nepenthes khasiana -a GC-MS study.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 284, doi. 10.1016/j.ipha.2023.10.005
- By:
- Publication type:
- Article
Works matching IS 2949866X AND DT 2024 AND VI 2 AND IP 2
Results: 12
1
2
Ziziphus mauritiana: An in-depth review of its medicinal attributes and pharmacological activities.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 274, doi. 10.1016/j.ipha.2023.12.001
- By:
- Publication type:
- Article
3
Simplifying the concept of level of evidence in lay language for all aspects of learners: In brief review.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 270, doi. 10.1016/j.ipha.2023.11.002
- By:
- Publication type:
- Article
4
Total parenteral nutrition: A boon to non-functional gastrointestinal patients.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 263, doi. 10.1016/j.ipha.2023.10.007
- By:
- Publication type:
- Article
5
A green alternative: Evaluation of Solanum torvum (Sw.) leaf extract for control of Aedes aegypti (L.) and its molecular docking potential.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 251, doi. 10.1016/j.ipha.2023.11.012
- By:
- Publication type:
- Article
6
Molecular docking studies of some benzoxazole and benzothiazole derivatives as VEGFR-2 target inhibitors: In silico design, MD simulation, pharmacokinetics and DFT studies.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 232, doi. 10.1016/j.ipha.2023.11.010
- By:
- Publication type:
- Article
7
Comparative evaluation of carvedilol and pitavastatin for antihyperlipidemic activity in tyloxapol-induced hyperlipidemia in Wistar rats.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 226, doi. 10.1016/j.ipha.2023.11.009
- By:
- Publication type:
- Article
8
Towards designing of some potential new autoimmune disorder inhibitors using crystal structures and Hirshfeld surface analyses in combination with molecular docking and molecular dynamics simulations.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 204, doi. 10.1016/j.ipha.2023.11.008
- By:
- Publication type:
- Article
9
Modelling of novel bornoel analogs as Influenza A Virus inhibitors through genetic function approximation, comparative molecular fields, molecular docking, and ADMET/Pharmacokinetic studies.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 190, doi. 10.1016/j.ipha.2023.11.004
- By:
- Publication type:
- Article
10
Risk factors for clinical treatment failure and death in patients with ceftazidime-avibactam-resistant Gram-negative bacteria: A single-centre retrospective analysis.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 183, doi. 10.1016/j.ipha.2023.11.003
- By:
- Publication type:
- Article
11
Docking study of novel designed indazole derivatives against topoisomerase-II DNA gyrase enzyme for antibacterial screening.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 173, doi. 10.1016/j.ipha.2023.11.001
- By:
- Publication type:
- Article
12
A novel anoikis-related gene signature predicts in lung adenocarcinoma.
- Published in:
- Intelligent Pharmacy, 2024, v. 2, n. 2, p. 161, doi. 10.1016/j.ipha.2023.10.013
- By:
- Publication type:
- Article